DF Dent & Co’s Eli Lilly LLY Stock Holding History

DF Dent & Co’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.85M	Sell	3,100 -1,367	-31%	-$1.39M	0.05%	119
2025 Q4	$4.8M	Buy	4,467 +7	+0.2%	+$6.69K	0.07%	111
2025 Q3	$3.4M	Buy	4,460 +1,242	+39%	+$924K	0.04%	120
2025 Q2	$2.51M	Buy	3,218 +670	+26%	+$521K	0.03%	122
2025 Q1	$2.1M	Sell	2,548 -318	-11%	-$265K	0.03%	130
2024 Q4	$2.21M	Sell	2,866 -422	-13%	-$349K	0.03%	128
2024 Q3	$2.91M	Sell	3,288 -190	-5%	-$171K	0.04%	122
2024 Q2	$3.15M	Hold	3,478	–	–	0.04%	112
2024 Q1	$2.71M	Sell	3,478 -16	-0.5%	-$11.4K	0.03%	119
2023 Q4	$2.04M	Buy	3,494 +61	+2%	+$35.6K	0.03%	119
2023 Q3	$1.84M	Sell	3,433 -21	-0.6%	-$10.8K	0.03%	129
2023 Q2	$1.62M	Sell	3,454 -35	-1%	-$14.7K	0.02%	131
2023 Q1	$1.2M	Sell	3,489 -650	-16%	-$219K	0.02%	146
2022 Q4	$1.51M	Sell	4,139 -1,228	-23%	-$435K	0.02%	126
2022 Q3	$1.74M	Sell	5,367 -3	-0.1%	-$951	0.03%	122
2022 Q2	$1.74M	Hold	5,370	–	–	0.02%	122
2022 Q1	$1.54M	Sell	5,370 -34	-0.6%	-$8.75K	0.02%	133
2021 Q4	$1.49M	Sell	5,404 -72	-1%	-$18.3K	0.02%	134
2021 Q3	$1.26M	Hold	5,476	–	–	0.01%	133
2021 Q2	$1.26M	Sell	5,476 -25	-0.5%	-$5.02K	0.01%	132
2021 Q1	$1.03M	Hold	5,501	–	–	0.01%	139
2020 Q4	$929K	Sell	5,501 -1,000	-15%	-$149K	0.01%	140
2020 Q3	$962K	Sell	6,501 -1,410	-18%	-$218K	0.01%	130
2020 Q2	$1.3M	Buy	7,911 +1,200	+18%	+$184K	0.02%	117
2020 Q1	$931K	Buy	6,711 +195	+3%	+$26.8K	0.02%	127
2019 Q4	$856K	Sell	6,516 -613	-9%	-$71.1K	0.01%	151
2019 Q3	$797K	Sell	7,129 -100	-1%	-$11.1K	0.01%	148
2019 Q2	$801K	Sell	7,229 -35	-0.5%	-$4.12K	0.01%	149
2019 Q1	$943K	Sell	7,264 -239	-3%	-$29.1K	0.02%	150
2018 Q4	$868K	Buy	7,503 +100	+1%	+$11.2K	0.02%	148
2018 Q3	$794K	Hold	7,403	–	–	0.02%	169
2018 Q2	$632K	Hold	7,403	–	–	0.01%	172
2018 Q1	$573K	Sell	7,403 -1,005	-12%	-$80.9K	0.01%	181
2017 Q4	$710K	Hold	8,408	–	–	0.02%	135
2017 Q3	$719K	Buy	8,408 +55	+0.7%	+$4.51K	0.02%	110
2017 Q2	$687K	Hold	8,353	–	–	0.02%	106
2017 Q1	$703K	Hold	8,353	–	–	0.02%	98
2016 Q4	$614K	Buy	8,353 +1,075	+15%	+$80.1K	0.02%	116
2016 Q3	$584K	Hold	7,278	–	–	0.02%	102
2016 Q2	$573K	Sell	7,278 -200	-3%	-$15.1K	0.02%	118
2016 Q1	$538K	Buy	7,478 +110	+1%	+$8.32K	0.02%	99
2015 Q4	$621K	Sell	7,368 -2,116	-22%	-$176K	0.02%	101
2015 Q3	$794K	Sell	9,484 -292	-3%	-$24.7K	0.02%	93
2015 Q2	$816K	Buy	9,776 +222	+2%	+$16.9K	0.02%	120
2015 Q1	$694K	Hold	9,554	–	–	0.02%	101
2014 Q4	$659K	Hold	9,554	–	–	0.02%	102
2014 Q3	$620K	Hold	9,554	–	–	0.02%	99
2014 Q2	$594K	Sell	9,554 -345	-3%	-$20.6K	0.01%	105
2014 Q1	$583K	Hold	9,899	–	–	0.01%	109
2013 Q4	$505K	Sell	9,899 -500	-5%	-$25K	0.01%	140
2013 Q3	$523K	Buy	10,399 +345	+3%	+$18.1K	0.01%	109
2013 Q2	$494K	Buy	+10,054	New	+$547K	0.01%	104

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

DF Dent & Co's LLY Position: Q1 2026 in Review

DF Dent & Co reduced its Eli Lilly (LLY) stake by 31% in Q1 2026, selling an estimated $1.39M and leaving 3,100 shares worth $2.85M. The position accounts for 0.05% of the portfolio, ranked #119.

DF Dent & Co first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.8M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

DF Dent & Co held 3,100 shares of Eli Lilly worth $2.85M as of Q1 2026.
DF Dent & Co sold 1,367 Eli Lilly shares in Q1 2026, an estimated $1.39M.
Eli Lilly made up 0.05% of DF Dent & Co's portfolio in Q1 2026, its #119 holding.
DF Dent & Co first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
DF Dent & Co's Eli Lilly position peaked at $4.8M in Q4 2025.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on DF Dent & Co's 13F filing for Q1 2026, filed 15 May 2026.